# A Study of Sodium Oligomannate (GV-971) in Participants With Mild to Moderate Alzheimer's Disease

Clinical trial · Green Valley (Shanghai) Pharmaceuticals Co., Ltd.

- Archive id: nct:NCT04520412
- Published: 2020-08-20
- Venue: ClinicalTrials.gov
- ClinicalTrials.gov: https://clinicaltrials.gov/study/NCT04520412
- Source URL: https://clinicaltrials.gov/study/NCT04520412
- Provenance: clinicaltrials

## Abstract

The purpose of this study is to evaluate the safety, tolerability and efficacy of GV-971 in mild to moderate Alzheimer's disease.

_Abstract reproduced under ClinicalTrials.gov (U.S. National Library of Medicine), data processed 2026-10-29T09:00:05; modifications: selected fields only; whitespace normalized; brief summary truncated to 2,000 characters._

## Trial details

- acronym: GREEN MEMORY
- status: SUSPENDED
- phase: PHASE3
- study type: INTERVENTIONAL
- enrollment: 2046
- sponsor: Green Valley (Shanghai) Pharmaceuticals Co., Ltd.
- conditions: Alzheimer Disease
- interventions: DRUG: GV-971; DRUG: Placebo
- start date: 2020-10-27
- start date type: ACTUAL
- primary completion date: 2025-12-01
- has results: false
- data source: ClinicalTrials.gov
- data processed: 2026-10-29T09:00:05
- modifications: selected fields only; whitespace normalized; brief summary truncated to 2,000 characters

Topics: [Alzheimer's, Parkinson's & Neurodegeneration](https://space-kitty.com/topics/neurodegeneration)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.